While there was little in their latest financial report to show that the acquisition took place, there was this statement. (Quoting gramara from stockhouse here)
{"The loss for the nine month period ended November 30, 2017 was higher than the loss for the nine month period ended November 30, 2016 mainly due to expenditures in regard to the Company’s proposed acquisition of MJ BioPharma"
http://thecse.com/sites/default/files/investorx/VIN/1801291220152512.pdf
}
Also, the news release from January 2nd said that the some 5 million warrants originally issued pursuant to a private placement related to the acquisition had been extended 6 months, to July.
Recent MBAIF News
- Emerging Markets Report: Meeting the Moment • InvestorsHub NewsWire • 11/21/2023 04:18:47 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM